Oral probiotics for reducing the colonization rate of streptococcus agalactiae in reproductive tract of pregnant women and its effect on vaginal and intestinal microecology

Oral probiotics for reducing the colonization rate of streptococcus agalactiae in reproductive tract of pregnant women, the prognosis of pregnant women with diabetes mellitus, and its effect on vaginal tract and intestinal microecology

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023122

Enrollment

Unknown

Registered

2019-05-12

Start date

2019-06-01

Completion date

Unknown

Last updated

2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy with genital streptococcus agalactis infection

Interventions

Case series:oral probiotics

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Be able to follow the requirements of clinical trial program and be willing to take the test and sign the informed consent; 2. The single late-gestation pregnant women in our hospital were examined and required to give birth in our hospital; 3. The laboratory department of our hospital reported a patient with positive streptococcus agalactiae in the genital tract.

Exclusion criteria

Exclusion criteria: 1. Patients who refused to sign the informed consent to participate in the test; 2. Twin and multiple pregnancies; 3. Use vaginal medicine, systemic antibiotics and antifungal therapy within two weeks after signing the consent form; 4. Combined with nausea, multiple organ dysfunction and other chronic wasting diseases.

Design outcomes

Primary

Measure	Time frame
infection rate of streptococcus agalactiae;	—

Contacts

Public ContactShilei Pan

Zhujiang Hospital of Southern Medical University

13602882918@163.com+86 13602882918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026